A
Live / Applied — Statement of use — final refusal mailed (as of 14 Oct 2025)
What this means for you
Not registered yet, but its 05 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97396858
- Mark type
- Word mark
- Filed
- 05 May 2022
- Published for opposition
- 27 Sept 2022
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials for others; pharmaceutical research and development services
Owner
- Editas Medicine, Inc., Cambridge, MA, US
- Editas Medicine, Inc., Cambridge, MA, US
Prosecution history
- 14 Jan 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 14 Jan 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 14 Oct 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 14 Oct 2025 — FINAL REFUSAL E-MAILED
- 14 Oct 2025 — SU - FINAL REFUSAL - WRITTEN
- 17 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Sept 2025 — ASSIGNED TO LIE
- 12 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Jun 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 04 Jun 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 18 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Mar 2025 — NON-FINAL ACTION E-MAILED
- 18 Mar 2025 — SU - NON-FINAL ACTION - WRITTEN
- 11 Mar 2025 — ASSIGNED TO EXAMINER